![]() He received undergraduate and doctoral degrees in Chemistry at the University of Bonn, Germany. He spent more than 16 years at Biogen and its predecessor Idec Pharmaceuticals, with increasing responsibilities in technology and process development, technical operations and engineering, and ultimately as Senior Vice President of Engineering and Technology. Jorg was most recently head of Chemistry, Manufacturing and Controls (CMC) at the Bill & Melinda Gates Medical Research Institute where he was responsible for end-to-end activities in CMC across the Institute’s portfolio of drugs, antibodies, vaccines, and related products. In this role, Technical Operations, and cGMP production will report to Jorg, and he will oversee Facilities & Security and Information Technology. A graduate of the University of Pennsylvania, Ted earned his medical degree at Vanderbilt, and received a graduate degree in Bioethics from Penn.Īs Executive Vice President, Pharmaceutical Sciences and Operations, Jorg will be responsible for developing Repertoire’s manufacturing, supply chain, and site infrastructure strategy. He has also served as Research Professor of Medicine at the Vanderbilt University School of Medicine. He also has held global leadership positions in drug development at Novartis, Covance, and Merck. Ted was most recently a Venture Partner at Novo Ventures and previously at Celgene, where he led Clinical Research and Development, Inflammation and Immunology. He oversees Clinical Program Management, Clinical Research, Clinical Operations and Regulatory. A graduate of Harvard University, Anne earned a Master of Business Administration degree from Columbia University.Īs Executive Vice President and Chief Medical Officer, Ted is responsible for developing, accelerating and executing the company’s clinical development portfolio, and providing medical expertise in decisions affecting the company’s clinical development programs. ![]() Equity Capital Markets Syndicate for Bank of America Merrill Lynch following Bank of America’s acquisition of Merrill Lynch in 2009, where she began her career in 1996. Earlier in her career, she served as Managing Director and Head of the U.S. Anne was the Bank of America New York City President, and served on the company’s management committee. ![]() Prior to joining Repertoire, Anne led Global Real Estate Services and Strategic Initiatives for Bank of America, where she was responsible for strategic investments in real estate and technology, as well as operational initiatives and company-wide efforts to drive responsible growth, including Operational Excellence and Capital and Scenario Planning Processes. “The company has made great strides over the past year, and with the addition of Anne to the team, we’re poised for continued success and growth.” “Anne’s deep experience across a wide range of strategic and financial planning disciplines will be invaluable to Repertoire as we execute transactions and research programs,” said John Cox. The appointments of Anne, Ted and Jorg mark the expansion of Repertoire Immune Medicines’ leadership team. Repertoire also announced the appointments of Theodore Reiss, MD, MBE, as Executive Vice President and Chief Medical Officer, and Jorg Thommes, PhD, as Executive Vice President, Pharmaceutical Sciences and Operations. Anne Walker, Executive Vice President and Chief Financial Officer, Repertoire Immune Medicines (Photo: Business Wire)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |